Oncology News Australia

Home
Australia
Surry Hills, NSW
Oncology News Australia

Publishers of oncologynews.com.au, The Oncology Newsletter, and producers of The Oncology Podcast Welcome to the Oncology Network Australia!

We are a small group of academic publishing, communications and digital professionals building resources for the oncology profession. We aim to bring you quality, appropriate and independent digital resources through our suite of websites and publications. We are proud to support scientific advances that will improve patient outcomes and to fill some of the gaps created by Australia’s diverse and challenging healthcare landscape. We hope to use our skills to support you by providing all the news you need in one innovative and easy-to-use place, as well as blogging and networking opportunities to advance our shared goals. We regularly work with a wide range of advertisers from a diverse range of specialities. These organisations include Pharmaceutical, Technology, Professional Development and Not-For-Profit organisations, (who we are able to offer significant discounts). We promote select products, services, resources, events, educational opportunities and positions vacant which are of active interest to and appropriate for our subscribers. If you seek to connect and present your product or service to this niche community you have come to the right place. Visit our advertising portal for more information.

22/10/2025

🎙️ We're thrilled to share a new podcast - our AGITG ASM 2025: Special Podcast Preview

In this episode, host Rachael Babin sits down with two stellar guests: Associate Professor Sina Vatandoust (AGITG ASM 2025 Convenor) and Associate Professor Margaret Lee (one of the local speakers).

They discuss how collaboration across Australia, the Asia-Pacific and beyond is helping translate promising concepts into clinical trials that make a real difference.

Key themes include:
• Early-onset cancer
• Global oncology insights
• Radiation oncology breakthroughs
• Survivorship at the heart of the conversation

For anyone working in gastro-intestinal cancers, clinical research or looking to stay ahead of emerging trials and collaborations, this is a great listen.

Tune in and get inspired ahead of AGITG ASM 2025 (24-27 Nov, Tarntanya/Adelaide).

👉 Listen via:

Our website: t.ly/ZKF16
Apple Podcasts: t.ly/9LDeX
Spotify: t.ly/6dond
YouTube: https://www.youtube.com/watch?v=f0ZmYdfLFu8

With thanks to the Australasian Gastro-Intestinal Trials Group (AGITG) & GI Cancer Institute

24/09/2025

"Radiotherapy f***s vaginas. I'd rather have a robot in my pelvis." Our unfiltered oncology experts tackle robotic surgery benefits, revolutionary RNA vaccines for pancreatic cancer and why removing the spleen might compromise cancer outcomes.

Check out the latest episode of The Oncology Journal Club Podcast, with thanks to Prof. Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson

Listen here: https://oncologynetwork.com.au/s3-e7-the-oncology-journal-club/
Also on YouTube: https://www.youtube.com/watch?v=V8c0ZWi61lE&t=97s

And Spotify, Apple Podcasts etc:

21/08/2025

No more 'hot potatoes'!

Genetic testing is transforming breast cancer care - it's the responsibility of the wider multi-disciplinary team (MDT).

But how can busy MDTs confidently integrate it into everyday practice?

In this episode of Beyond the Slide, Rachael Babin is joined by genetic counsellor Amy Pearn and breast surgeon A/Prof Kylie Snook to unpack practical strategies, demystify Medicare item numbers and share tools to support clinicians.

Tune in for expert tips to help you deliver more personalised care and stay ahead of evolving practice.

https://oncologynetwork.com.au/breast-episode-5-mainstreaming-with-confidence/

27/07/2025

🚨 New Episode Alert! 🎧

Season 3, Episode 6 of The Oncology Journal Club is now live!

Join Professor Craig Underhill, Dr. Kate Clarke and Professor Christopher Jackson as they explore the latest in cancer research and care.

In this episode, they discuss:

🧬 Non-operative management of MMR-deficient tumours
📊 New global standards for clinical trial design
🎯 Advances in HER2-negative metastatic breast cancer
🌈 Conversations about hope, optimism and survival
🍼 Fertility preservation guidelines
And much more!

It’s a fast-paced, insightful episode packed with expert analysis, clinical pearls and trademark humour. Listen here for Show Notes t.ly/9iz1C or wherever you get your podcasts.

13/07/2025

NEW PODCAST ALERT! https://oncologynetwork.com.au/breast-episode-5-mainstreaming-with-confidence/
In the latest episode of Beyond the Slide, we explore one of the most significant shifts in modern breast cancer care — genetic mainstreaming.

Join host Rachael Babin for a practical conversation with genetic counsellor Amy Pearn and breast surgeon Associate Professor Kylie Snook, as they share insights and real-world strategies to help MDTs confidently integrate genetic testing into routine practice.

What’s covered:

- Understanding the benefits and timing of genetic testing in breast cancer
- Medicare item numbers explained — 73295 and 73296 demystified
- Tools to support clinicians, including the Genetics Advisor tool and EviQ education modules
- Common barriers and how to overcome them
- Why mainstreaming matters — for both patients and their families

Perfect for clinicians wanting to upskill and implement genetic mainstreaming confidently in their practice. Listen for expert tips to help you stay ahead of evolving practice and deliver more personalised cancer care.

10/07/2025

🌿 Breakthrough for rare cancer patients?
Aussie biotech QBiotics has just released promising early results from their soft tissue sarcoma trial — and it’s turning heads.

They’re using a compound called tigilanol tiglate (EBC-46), derived from a rainforest plant, and injecting it directly into tumours. In Stage I of their Phase IIa trial, they saw an 80% objective response rate in the injected tumours. That’s a big deal in the world of rare cancers, where effective treatment options are often limited.

What makes this especially exciting is how the drug works — not just destroying tumour cells but also activating the immune system to clean up and potentially target remaining cancer cells.

Still early days but it’s a step forward and one worth watching.

👉 Read more on Oncology News:
https://oncologynews.com.au/tumour-stream/rare-cancers/qbiotics-reports-80-objective-response-rate-in-injected-tumours-in-stage-i-of-phase-iia-soft-tissue-sarcoma-trial/

15/05/2025

🎧 Supportive Care Matters – Episode 2: No Longer Invisible

Join Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM, as she hosts the latest episode of Supportive Care Matters: Addressing the unique challenges of metastatic cancer survivorship

In this episode, Professor Koczwara is joined by researchers Associate Professor Nick Hart and Dr. Andrea Smith (who herself lives with metastatic breast cancer) to explore the unique challenges faced by those living with advanced cancer.
Oncology News

As treatment advances allow people with metastatic cancer to live longer, we're witnessing the emergence of a population that exists in what medical oncologist Dr. Lori Spoozak calls "the place in between" – not curable but not actively dying.

This eye-opening conversation delves into:

- Redefining Cancer Survivorship
- Unique Needs of Metastatic Cancer Patients
- Living in "The Place in Between"
- Redesigning Healthcare Models and Support
- International Standards for Metastatic Survivorship
- Global Challenges in Metastatic Care
- Future Directions and Research Priorities

🎙️ Listen now to understand the evolving landscape of cancer survivorship and the importance of addressing the unique needs of metastatic cancer patients.

👉 https://oncologynews.com.au/clinical-focus/survivorship-featured-news/episode-2-no-longer-invisible/

09/05/2025

🎙️ WEEKEND LISTENING: Breaking Down Silos - How MPCCC is Transforming Cancer Care

How can we deliver precision oncology at scale while ensuring equitable access for all patients?

In this episode, we chat to Professor Mark Shackleton who shares practical insights into transforming multidisciplinary care, improving access to precision oncology treatments and tackling inequities in Victoria.

Essential listening for oncology clinicians and healthcare professionals committed to evidence-based, equitable cancer care.

🎧 Listen via our website: http://t.ly/RiPv1 Also available on YouTube, Apple Podcasts, Spotify and wherever you get your podcasts

10/04/2025

From Consensus to Clinic: A Two-Part Podcast Series

Join Professor Tim Price and Professor Jeanne Tie for an insightful analysis on a recent expert consensus publication on molecular testing and treatment sequencing of BRAFV600E-mutant metastatic colorectal cancer in the Asia-Pacific region

Listen here: https://oncologynetwork.com.au/category/podcasts/from-consensus-to-clinic/

09/04/2025

🚨 Lung Cancer Screening Symposium 2025

Join leading experts, clinicians and researchers for a deep dive into the future of lung cancer screening in Australia. This full-day in-person and online symposium will explore the upcoming National Lung Cancer Screening Program, implementation challenges, and the latest evidence and innovations in the field.

📅 Date: Wednesday, 23 May 2025
📍 Location: Melbourne
🕘 Time: 9:00am – 5:00pm AEST
🎟️ Register now: https://vcccalliance.org.au/news-and-events/events/lung-cancer-screening-symposium

Don't miss this important event for professionals involved in lung cancer care, screening, policy, research and implementation.

✅ Limited spaces available – secure your spot today!

26/03/2025

NEW PODCAST EPISODE!

Join host Rachael Babin alongside Professor Timothy Price and Professor Jeanne Tie as they continue the discussion on BRAFV600E-mutant metastatic colorectal cancer in this second instalment of From Consensus to Clinic.

The experts share practical insights on:

- The frequency of imaging for optimal patient monitoring

- The role of ctDNA and tumour markers in guiding treatment decisions

- The use of PET scans and advanced imaging techniques

- Management of oligometastatic disease and the role of local ablative therapies

- The importance of repeat biopsies and genomic testing in later-line settings

- Encouraging clinical trial enrolment to advance treatment options

A must-listen for those involved in GI cancer care: https://oncologynetwork.com.au/from-consensus-to-clinic-part-2/

Thanks to Pierre Fabre Laboratories for commissioning another informative educational resource.

20/03/2025

🎙️ New Podcast Episode! 🎙️

Is Diversity, Equity, and Inclusion (DEI) in healthcare dead? 🤔 In this episode of The Oncology Journal Club podcast, our expert panel dives into the future of DEI in oncology, exploring its impact, challenges and what’s next for equitable cancer care.

Hosted by the indefatigable Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson.

Don’t miss this insightful discussion! Listen now: https://oncologynews.com.au/podcasts/s3e2-the-oncology-journal-club-is-dei-dead-the-future-of-diversity-equity-and-inclusion-in-healthcare/ for links to papers or wherever you get your podcasts

🔁 Share your thoughts in the comments—what does this mean for the future of healthcare?

Address

Surry Hills, NSW
2010

Website

http://oncologynews.com.au/, http://www.oncologynetwork.com.au/

Alerts

Be the first to know and let us send you an email when Oncology News Australia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Surry Hills?